Italia markets closed

ILMN Dec 2024 60.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
1,90000,0000 (0,00%)
Alla chiusura: 02:20PM EDT
Schermo intero
Chiusura precedente1,9000
Aperto1,9000
Denaro0,0000
Lettera9,6000
Prezzo d'esercizio60,00
Scadenza2024-12-20
Min-Max giorno1,9000 - 1,9000
Contratto - Min-MaxN/D
Volume1
Open Interest2
  • GlobeNewswire

    Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials

    Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only testSALT LAKE CITY, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced two key milestones in its strategic partnership with Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, to advance and support clinical research for gene-based, targeted thera